← Back to Analyst Consensus 
NVS Hold
NOVARTIS AG
Current Price —
Implied Upside —
Analysts 34
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 10, 2026 | HSBC | upgrade | Reduce → Hold | — | 53% |
| Mar 26, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jan 6, 2026 | Barclays | upgrade | Underweight → Equal-Weight | $0 | 53% |
| Dec 8, 2025 | JP Morgan | upgrade | Neutral → Overweight | $0 | 55% |
| Sep 12, 2025 | Goldman Sachs | downgrade | Neutral → Sell | $118 | 54% |
| Feb 13, 2025 | UBS | downgrade | Buy → Neutral | $0 | 54% |
| Nov 19, 2024 | Erste Group | downgrade | Buy → Hold | $0 | 52% |
| Oct 30, 2024 | BMO Capital | maintain | Market Perform → Market Perform | $120 | 53% |
| Sep 11, 2024 | B of A Securities | downgrade | Buy → Neutral | $130 | 53% |
| Sep 5, 2024 | Goldman Sachs | downgrade | Buy → Neutral | $121 | 54% |
| Sep 3, 2024 | Jefferies | downgrade | Buy → Hold | $0 | 52% |
| Jul 2, 2024 | Jefferies | maintain | Buy → Buy | $122.5 | 52% |
| Apr 24, 2024 | BMO Capital | maintain | Market Perform → Market Perform | $116 | 53% |
| Feb 23, 2024 | BMO Capital | initiate | — → Market Perform | $114 | 53% |
| Jan 23, 2024 | Morgan Stanley | initiate | — → Equal-Weight | $114 | 54% |
| Sep 25, 2023 | Morgan Stanley | upgrade | Underweight → Equal-Weight | $0 | 54% |
| May 9, 2022 | Wolfe Research | downgrade | Outperform → Peer Perform | $0 | 54% |
| Dec 6, 2021 | Exane BNP Paribas | downgrade | Outperform → Neutral | $0 | 52% |
| Dec 3, 2021 | Bryan Garnier | downgrade | Buy → Neutral | $0 | — |
| Sep 20, 2021 | Deutsche Bank | downgrade | Hold → Sell | $0 | 57% |
| Mar 10, 2021 | Argus Research | downgrade | Buy → Hold | $0 | 54% |
| Feb 1, 2021 | Cowen & Co. | downgrade | Outperform → Market Perform | $105 | — |
| Jan 15, 2021 | Deutsche Bank | initiate | — → Buy | $0 | 57% |
| Sep 1, 2020 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $0 | 54% |
| Feb 25, 2020 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Apr 25, 2019 | Guggenheim | upgrade | Neutral → Buy | $0 | 52% |
| Apr 10, 2019 | Morgan Stanley | downgrade | Equal-Weight → Underweight | $0 | 54% |
| Nov 26, 2018 | Cowen & Co. | upgrade | Market Perform → Outperform | $100 | — |
| Nov 19, 2018 | Goldman Sachs | upgrade | Neutral → Conviction Buy | $0 | 54% |
| Sep 11, 2018 | Citigroup | upgrade | Neutral → Buy | $0 | 54% |
| Sep 10, 2018 | B of A Securities | upgrade | Underperform → Buy | $0 | 53% |
| Jul 19, 2018 | Barclays | upgrade | Underweight → Equal-Weight | $0 | 53% |
| May 29, 2018 | HSBC | downgrade | Buy → Hold | $0 | 53% |
| May 25, 2018 | Credit Suisse | upgrade | Underperform → Neutral | $0 | — |
| Jan 25, 2018 | Leerink Swann | maintain | Market Perform → Market Perform | $100 | — |
| Oct 25, 2017 | Barclays | downgrade | Equal-Weight → Underweight | $0 | 53% |
| Oct 23, 2017 | Leerink Swann | maintain | — → Market Perform | $91 | — |
| Jul 26, 2017 | Morgan Stanley | upgrade | Underweight → Overweight | $0 | 54% |
| Jul 5, 2017 | Credit Suisse | downgrade | Neutral → Underperform | $0 | — |
| Apr 5, 2017 | Cowen & Co. | downgrade | Outperform → Market Perform | $77 | — |
| Jan 11, 2017 | Credit Suisse | downgrade | Outperform → Neutral | $0 | — |
| Jan 3, 2017 | JP Morgan | downgrade | Overweight → Neutral | $0 | 55% |
| Nov 10, 2016 | Argus Research | upgrade | Hold → Buy | $0 | 54% |
| Sep 20, 2016 | Chardan Capital | initiate | — → Buy | $95 | 47% |
| Apr 12, 2016 | Morgan Stanley | downgrade | Equal-Weight → Underperform | $0 | 54% |
| Apr 5, 2016 | Argus Research | initiate | — → Hold | $0 | 54% |
| Apr 1, 2016 | UBS | downgrade | Buy → Neutral | $0 | 54% |
| Mar 29, 2016 | Citigroup | downgrade | Buy → Neutral | $0 | 54% |
| Mar 23, 2016 | Leerink Swann | downgrade | Outperform → Market Perform | $85 | — |
| Oct 28, 2015 | MainFirst Bank AG | downgrade | — → Underperform | $0 | — |
Price Target Trend
Jul 23, 2026 Oct 26, 2026
EPS Estimates
+1q —
0y —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days